Featured Share Your Research

Fengping Shan

Dr. Fengping Shan is the Chief Science Officer and a former member of the Board of Directors at Immune Therapeutics. Dr. Shan has a Ph.D. in Microbiology and Tumor Immunology.  Dr. Shan is Professor of Immunology and Vice Director of the Institute of Immunology, China Medical University, in Shenyang, China. Professor Shan has been with the University from 2006 to present.

Dr. Shan was the Senior Scientist for Penta Biotech from 2000 to 2006, Chief Scientist for the China Liaoning Institute of Microbiological Science from 1995 to 2000 and studied at the National Cancer Research in Paris, France from 1990 to 1994. Dr. Shan has authored 90 publications, been issued 11 patents, and is the unique inventor of a thrombolytic enzyme from the earthworm. From 2000 to present, Dr. Shan has worked both in the United States and China on the clinical trials with Dr. Nicholas Plotnikoff involving new immunotherapies for the treatment of cancer. Based on the trials, a number of patents were filed in China beginning in 2009 and 2010, and approved in 2011.

The Plan Of Four-Dimensional Regulation (4D Plan) For Cancer Patients: First Systematic Plan For Cancer Patients In The World

Cancer is still a global issue. Surgery, chemotherapy, radiotherapy, and present immune therapy do prolong the lives of cancer patients, but these cannot correct a disordered immune system, a result of cancer. Free radicals are often hazardous to patients and […]